These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8405002)

  • 1. Disparate effects of a triglyceride lowering diet and of bezafibrate on the HDL system: a study in patients with hypertriglyceridaemia and low HDL-cholesterol levels.
    Arnon R; Sehayek E; Eisenberg S
    Eur J Clin Invest; 1993 Aug; 23(8):492-8. PubMed ID: 8405002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.
    Gavish D; Oschry Y; Fainaru M; Eisenberg S
    Eur J Clin Invest; 1986 Feb; 16(1):61-8. PubMed ID: 3084275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients. Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum.
    Vessby B; Lithell H
    Atherosclerosis; 1990 May; 82(1-2):137-43. PubMed ID: 2360915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol.
    Blades B; Vega GL; Grundy SM
    Arterioscler Thromb; 1993 Aug; 13(8):1227-35. PubMed ID: 8343498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia.
    Föger B; Ritsch A; Doblinger A; Wessels H; Patsch JR
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1430-6. PubMed ID: 8977446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.
    Totsuka M; Miyashita Y; Ito Y; Watanabe H; Murano T; Shirai K
    Atherosclerosis; 2000 Nov; 153(1):175-9. PubMed ID: 11058713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum triglyceride clearance and elevated high-density lipoprotein 2 and 3 cholesterol during treatment of primary hypertriglyceridemia with bezafibrate.
    Sakuma N; Ikeuchi R; Hibino T; Yoshida T; Mukai S; Akita S; Yajima K; Miyabe H; Goto T; Takada N; Ohte N; Kunimatu M; Kimura G
    Curr Ther Res Clin Exp; 2003 Nov; 64(9):697-706. PubMed ID: 24944417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels.
    Cominacini L; Garbin U; Davoli A; Campagnola M; De Santis A; Pasini C; Pastorino AM; Bosello O
    Ann Nutr Metab; 1993; 37(4):175-84. PubMed ID: 8215234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of triglycerides and HDL cholesterol in hypertriglyceridemia.
    Avogaro P; Ghiselli G; Soldan S; Bittolo Bon G
    Atherosclerosis; 1992 Jan; 92(1):79-86. PubMed ID: 1575823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postheparin lipolytic activity and plasma lipoprotein response to omega-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia.
    Nozaki S; Garg A; Vega GL; Grundy SM
    Am J Clin Nutr; 1991 Mar; 53(3):638-42. PubMed ID: 2000816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
    Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
    J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation.
    Nishiwaki M; Ishikawa T; Ito T; Shige H; Tomiyasu K; Nakajima K; Kondo K; Hashimoto H; Saitoh K; Manabe M
    Atherosclerosis; 1994 Nov; 111(1):99-109. PubMed ID: 7840818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
    Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S
    Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
    Iglesias A; Contreras JA; Martínez-Pardo M; Entrala A; Herrera E; Lasunción MA
    Clin Chim Acta; 1993 Nov; 221(1-2):73-89. PubMed ID: 8149644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
    Kobayashi J; Takahashi K; Tashiro J; Shirai K; Saito Y; Yoshida S; Hashimoto H; Fukamachi I; Niihara K; Sasaki N
    Arzneimittelforschung; 1994 Feb; 44(2):145-8. PubMed ID: 8147947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
    Winocour PH; Durrington PN; Bhatagnar D; Ishola M; Mackness M; Arrol S; Anderson DC
    Atherosclerosis; 1992 Mar; 93(1-2):83-94. PubMed ID: 1596307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
    De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
    Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia.
    Miida T; Sakai K; Ozaki K; Nakamura Y; Yamaguchi T; Tsuda T; Kashiwa T; Murakami T; Inano K; Okada M
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2428-33. PubMed ID: 11073848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
    Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
    Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high-density lipoprotein subfractions and composition.
    Stubbe I; Hansson P; Gustafson A; Nilsson-Ehle P
    Metabolism; 1983 Dec; 32(12):1120-8. PubMed ID: 6417447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.